Green Market Report: DEA rejects speakers for November hearings on two psychedelic compounds
We are grateful to Debra Borchardt from Green Market Report for her coverage on the DOI/DOC hearings published on October 4, 2024.
“What is the DEA so scared of that these leading scientists must be muzzled?” said Robert Rush, a Denver-based attorney who is working hand-in-hand with SSDP to keep research using DOI and DOC legal. “By trying to silence the world’s leading experts in neuroscience and pharmacology, the DEA is attempting to prevent the tribunal – and the public – from understanding the true potential of these substances.”
Later in the article, Elijah Ullman, a Ph.D. candidate in molecular and systems pharmacology at Emory University and chair of SSDP’s Science Policy Committee, stated
“If the DEA believes that both DOI and DOC should be placed in Schedule I, they should have no issue allowing our witnesses to testify in full – after all, don’t they allege they have sufficient data to prove DOI and DOC are addictive and a harm to the public?”
“If the DEA believed their own rhetoric and description of the data, they would allow our proposed witnesses to testify in full. Otherwise, it appears to me that they are worried their dataset is lacking the scientific rigor to support their claims.”
Read the complete article in Green Market Report here.
